Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
April 18, 2024 17:24 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the...
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
April 01, 2024 16:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully...
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
March 11, 2024 08:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
February 28, 2024 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences Announces Leadership Transition Plan
February 28, 2024 06:00 ET
|
Integra LifeSciences Holdings Corporation
Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings...
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
February 07, 2024 09:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year...
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 05, 2024 16:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
December 13, 2023 06:15 ET
|
Integra LifeSciences Holdings Corporation
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the...
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
December 12, 2023 12:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D.,...
Integra LifeSciences Reports Third Quarter 2023 Financial Results
October 25, 2023 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...